Canandaigua National Bank & Trust’s Biogen BIIB Stock Holding History

Canandaigua National Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-884	Closed	-$207K	–	284
2019 Q2	$207K	Sell	884 -15	-2%	-$3.46K	0.04%	254
2019 Q1	$213K	Buy	899 +105	+13%	+$33.1K	0.04%	254
2018 Q4	$239K	Sell	794 -8	-1%	-$2.55K	0.05%	238
2018 Q3	$283K	Sell	802 -289	-26%	-$99.5K	0.05%	247
2018 Q2	$317K	Buy	1,091 +84	+8%	+$23.6K	0.06%	228
2018 Q1	$276K	Buy	+1,007	New	+$313K	0.04%	298
2016 Q4	–	Sell	-647	Closed	-$203K	–	191
2016 Q3	$203K	Buy	+647	New	+$192K	0.06%	190
2016 Q1	–	Sell	-697	Closed	-$214K	–	196
2015 Q4	$214K	Sell	697 -238	-25%	-$68.4K	0.07%	183
2015 Q3	$273K	Buy	935 +38	+4%	+$12.5K	0.09%	165
2015 Q2	$362K	Buy	+897	New	+$360K	0.11%	149

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Canandaigua National Bank & Trust's BIIB Position: Q3 2019 in Review

Canandaigua National Bank & Trust sold out of Biogen (BIIB) in Q3 2019, closing a stake of 884 shares — an estimated $207K sold.

Canandaigua National Bank & Trust first reported a position in BIIB in Q2 2015 and held it in 10 quarters. The position peaked at $362K in Q2 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Canandaigua National Bank & Trust reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Canandaigua National Bank & Trust sold 884 Biogen shares in Q3 2019, an estimated $207K.
Canandaigua National Bank & Trust first reported a position in Biogen in Q2 2015 and held it in 10 quarters.
Canandaigua National Bank & Trust's Biogen position peaked at $362K in Q2 2015.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2019, filed 13 Nov 2019.